Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lyndsey Bolanos

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Medicine|June 14, 2016
A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromesJing Fang, Xiaona Liu, Lyndsey Bolanos, et al.
Blood|June 12, 2012
Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1Jing Fang, Garrett Rhyasen, Lyndsey Bolanos, et al.
Cell Reports|September 10, 2014
Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene networkJing Fang, Brenden Barker, Lyndsey Bolanos, et al.
Nature|April 24, 2025
Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1Puneet Agarwal, Avery Sampson, Kathleen Hueneman, et al.
Cancer Cell|July 13, 2013
Targeting IRAK1 as a therapeutic approach for myelodysplastic syndromeGarrett W Rhyasen, Lyndsey Bolanos, Jing Fang, et al.
The Journal of Clinical Investigation|March 10, 2020
Targeting AML-associated FLT3 mutations with a type I kinase inhibitorLaQuita M Jones, Katelyn Melgar, Lyndsey Bolanos, et al.
Haematologica|November 2, 2023
<i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasmsVladimir Riabov, Qingyu Xu, Nanni Schmitt, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Medicine|June 14, 2016
A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromesJing Fang, Xiaona Liu, Lyndsey Bolanos, et al.
Blood|June 12, 2012
Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1Jing Fang, Garrett Rhyasen, Lyndsey Bolanos, et al.
Cell Reports|September 10, 2014
Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene networkJing Fang, Brenden Barker, Lyndsey Bolanos, et al.
Nature|April 24, 2025
Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1Puneet Agarwal, Avery Sampson, Kathleen Hueneman, et al.
Cancer Cell|July 13, 2013
Targeting IRAK1 as a therapeutic approach for myelodysplastic syndromeGarrett W Rhyasen, Lyndsey Bolanos, Jing Fang, et al.
The Journal of Clinical Investigation|March 10, 2020
Targeting AML-associated FLT3 mutations with a type I kinase inhibitorLaQuita M Jones, Katelyn Melgar, Lyndsey Bolanos, et al.
Haematologica|November 2, 2023
<i>ASXL1</i> mutations are associated with a response to alvocidib and 5-azacytidine combination in myelodysplastic neoplasmsVladimir Riabov, Qingyu Xu, Nanni Schmitt, et al.
Pageof 1